COMBINATION THERAPY OF PROSTATITIS-ASSOCIATED COPULATIVE DYSFUNCTION
- Authors: Blumberg B.I1, Shatylko T.V1, Tverdokhleb S.A1, Fomkin R.N1, Voskoboynikova I.V2
-
Affiliations:
- SBEI HPE «Saratov State Medical University n.a V.I. Razumovsky» of RMPH
- ZAO «FPK PharmVILAR»
- Issue: No 6 (2014)
- Pages: 27-32
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/280333
- ID: 280333
Cite item
Abstract
Chronic prostatitis is characterized by clinical polymorphism, that may include pain, dysuria, asthenovegetative syndrome, and others. Symptoms associated with impaired copulatory cycle in chronic prostatitis have a significant impact on the quality of life of patient. Sexual dysfunction and sexuality cessation can exacerbate the inflammation of the prostate gland and worsen the underlying disease. The study included 60 patients diagnosed with chronic bacterial prostatitis, complicated by sexual disorders. Patients were divided into two comparable groups of 30 persons. Control group of patients received standard antibacterial therapy; study group of patients in addition received phytodrug prostanorm. At the end of treatment, higher IIEF-5 scores, increasing number of lecithin granules in the prostate secretion, as well as reducing the severity of irritative symptoms were registered in the study group.
Keywords
Full Text
About the authors
B. I Blumberg
SBEI HPE «Saratov State Medical University n.a V.I. Razumovsky» of RMPH
T. V Shatylko
SBEI HPE «Saratov State Medical University n.a V.I. Razumovsky» of RMPH
Email: shatylko@sar-urology.ru
S. A Tverdokhleb
SBEI HPE «Saratov State Medical University n.a V.I. Razumovsky» of RMPH
R. N Fomkin
SBEI HPE «Saratov State Medical University n.a V.I. Razumovsky» of RMPH
I. V Voskoboynikova
ZAO «FPK PharmVILAR»
References
- Lee K.S., Choi J.D. Chronic prostatitis: approaches for best management. Korean J Urol. 2012;53(2):69-77.
- Глыбочко П.В., Чураков А.А., Попков В.М. и др. Хронический инфекционный простатит. Материалы VI Российского конгресса «Мужское здоровье». 2010. С. 24-35.
- Wagenlehner F., Pilatz A., Linn T. et al. Prostatitis and andrological implications. Minerva Urol Nefrol. 2013;65(2):117-123.
- Рудницкий Р.И. Хронический простатит как причина нарушения сексуального здоровья супругов. Международный медицинский журнал. 2005;2:57-59.
- Trinchieri A., Magri V., Cariani L. et al. Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome. Arch Ital Urol Androl. 2007;79(2):67-70.
- Висмонт Ф.И. Воспаление (патофизиологические аспекты): уч. метод. пособие. Мн.: БГМУ, 2006. 48 с.
- Акопян А.С., Корякин М.В. Биомедицинские и психосоциальные аспекты эректильной дисфункции. Лечащий Врач. 2007;4:44-46.
- Shoskes D.A. The challenge of erectile dysfunction in the man with chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep. 2012;13(4):263-267.
- Gao J., Xu C., Liang C. Relationships Between Intravaginal Ejaculatory Latency Time and National Institutes of Health-Chronic Prostatitis Symptom Index in the Four Types of Premature Ejaculation Syndromes: A Large Observational Study in China. J Sex Med. 2014 Oct 13.
- Tang D., Zhang X., Hao Z. et al. Prevalence of prostatitis-like symptoms in outpatients with four premature ejaculation syndromes: a study in 438 men complaining of ejaculating prematurely. Int J Clin Exp Med. 2014;7(7):1829-1836.
- Sönmez N.C., Kiremit M.C., Güney S. et al. Sexual dysfunction in type III chronic prostatitis (CP) and chronic pelvic pain syndrome (CPPS) observed in Turkish patients. Int Urol Nephrol. 2011;43(2):309-314.
- Courtois F., Carrier S., Charvier K. et al. The control of male sexual responses. Curr Pharm Des. 2013;19(24):4341-4356.
- Celik O., Ipekci T., Akarken I. et al. To evaluate the etiology of erectile dysfunction: What should we know currently? Arch Ital Urol Androl. 2014;86(3):197-201.
- Патофизиология : учебник : в 2 т. / Под ред. В.В. Новицкого, Е.Д. Гольдберга, О.И. Уразовой. 4-е изд., перераб. и доп. ГЭОТАР-Медиа, 2009;1:848.
- Snow D.C., Shoskes D.A. Pharmacotherapy of prostatitis. Expert Opin Pharmacother. 2010;11(14):2319-2330.
- Suh L.K., Lowe F.C. Alternative therapies for the treatment of chronic prostatitis. Curr Urol Rep. 2011;12(4):284-287.
- Herati A.S., Moldwin R.M. Alternative therapies in the management of chronic prostatitis/chronic pelvic pain syndrome. World J Urol. 2013;31(4):761-766.
- Белобородов В.Л., Захарова Н.Г., Савватеев А.М. и др. Разделение и идентификация компонентов комплексного фитопрепарата простанорм методом ВЭЖХ. Химико-фармацевтический журнал. 2011;45(9):33-36.
- Ситдыкова М.Э., Перчаткин В.А. Опыт применения препарата простанорм в лечении больных хроническим простатитом. Казанский медицинский журнал. 2002;83(4).
- LeMay P.H. Prostatitis and Licorice. Can J Urol. 1999;6(5):878.
- Shoskes D.A., Nickel J.C. Quercetin for chronic prostatitis/chronic pelvic pain syndrome. Urol Clin North Am. 2011;38(3):279-284.
- Dapas B., Dall'Acqua S., Bulla R. et al. Immunomodulation mediated by a herbal syrup containing a standardized Echinacea root extract: A pilot study in healthy human subjects on cytokine gene expression. Phytomedicine. 2014.
- Capasso R., Borrelli F., Montanaro V. et al. Effects of the antidepressant St. John's wort (Hypericum perforatum) on rat and human vas deferens contractility. J Urol. 2005;173(6):2194-2197.
- Ahuja S.K. Chronic bacterial prostatitis workup. Medscape. 2013. URL: http://emedicine.medscape.com/article/458391-workup (дата обращения: 09.06.2014).
- Grabe M., Bartoletti R., Bjerklund-Johansen T.E. et al. Guidelines on Urological Infections. European Association of Urology. 2014;69-70.
- Crofts M., Mead K., Persad R. et al. How to manage the chronic pelvic pain syndrome in men presenting to sexual health services. Sex Transm Infect. 2014;90(5):370-373.